During the past decade, Overlake Internal Medicine Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Overlake Internal Medicine Associates" #1 collaborator was "NRG Oncology" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Overlake Internal Medicine Associates" are "Alzheimer's Disease" (1 trials), "Breast Ductal Carcinoma In Situ" (1 trials), "HER2/Neu Positive" (1 trials), "Mammographic Breast Density" (1 trials) and "Optim Lead Insulation Related Adverse Events" (1 trials). Many other conditions were trialed in "Overlake Internal Medicine Associates" in a lesser frequency.

Most popular intervention types in "Overlake Internal Medicine Associates" are "Drug" (3 trials), "Biological" (2 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Trastuzumab" (2 trials), "4-OH tamoxifen" (1 trials), "Cyclophosphamide" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Overlake Internal Medicine Associates" are 3 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Overlake Internal Medicine Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Overlake Internal Medicine Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Overlake Internal Medicine Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".